Table 3 |
|||||
|
Outcomes |
|||||
|
Outcome |
Baxter group (n = 14) |
HES group (n = 16) |
Adjusted hazard ratio or mean difference (95% CI, P value)# |
||
|
|
|||||
|
Mortality |
Overall mortality (%) |
2 (14.3) |
7 (43.8) |
Hazard ratio: 7.12 (0.45-112.7, P = 0.16) |
|
|
|
|||||
|
Renal parameters |
Continuous renal replacement therapy (%) |
1 (7.1) |
4 (25.0) |
Hazard ratio: 6.16 (0.07-505.7, P = 0.42) |
|
|
Creatinine clearance |
24 hours |
125.9 (20.1) |
102.5 (38.8) |
Mean difference: -6.5 (-26.8 to 13.7, P = 0.51) |
|
|
48 hours |
125.9 (25.6) |
95.6 (40.3) |
Mean difference: -14.7 (-37.8 to 8.4, P = 0.20 |
||
|
72 hours |
124.2 (33.4) |
97.4 (47.2) |
Mean difference: -4.8 (-28.3 to 18.6, P = 0.67) |
||
|
Urinary output |
72 hours |
165.1 (53.1) |
135.8 (59.3) |
Mean difference: -9.7 (-56.6 to 37.2, P = 0.67) |
|
|
|
|||||
|
Pulmonary parameters |
ARDS (%) |
4 (28.6) |
3 (18.8) |
Hazard ratio: 1.26 (0.14-11.35, P = 0.84) |
|
|
Ventilator days |
7.4 (11.0) |
12.3 (19.7) |
Mean difference: -2.4 (-12.9 to 8.2, P = 0.65) |
||
|
Horowitz |
72 hours |
237.2 (98.3) |
225.4 (85.7) |
Mean difference: 17.5 (-51.7 to 86.6, P = 0.61) |
|
|
|
|||||
|
Surgical parameters |
Beginning of surgical treatment within first 3 days (%) |
10 (71.4) |
9 (56.3) |
Hazard ratio: 2.00 (0.58-6.93, P = 0.27) |
|
|
Time to complete surgical coverage (days) |
23.0 (15.7) |
31.9 (30.8) |
Mean difference: 1.7 (-25.2 to 28.6, P = 0.89) |
||
|
|
|||||
|
Other parameters |
Sepsis (%) |
5 (35.7) |
6 (37.5) |
Hazard ratio: 0.95 (0.16-5.56, P = 0.95) |
|
|
Hospital days |
32.4 (16.1) |
28.6 (20.7) |
Mean difference: -6.7 (-22.9 to 9.6, P = 0.40) |
||
|
ICU days |
27.0 (14.1) |
23.6 (17.4) |
Mean difference: -7.6 (-21.1 to 5.8, P = 0.25) |
||
|
|
|||||
|
# Multivariable logistic regression analysis or linear regression analysis with outcome as independent and groups as dependent variable with adjustment for age, gender percent burn, acute physiology and chronic health evaluation (APACHE) II, baseline creatinine. ARDS, adult respiratory distress syndrome; CI, confidence interval; HES, hydroxyethyl starch. |
|||||
|
Béchir et al. Critical Care 2010 14:R123 doi:10.1186/cc9086 |
|||||